Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma

[1]  Yuanliang Yan,et al.  A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma , 2021, Frontiers in Cell and Developmental Biology.

[2]  Yueli Zhang,et al.  Long noncoding RNA SNHG6 promotes oesophageal squamous cell carcinoma by downregulating the miR‐101‐3p/EZH2 pathway , 2021, Journal of biochemical and molecular toxicology.

[3]  P. Xue,et al.  Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2 , 2021, Cell Death & Differentiation.

[4]  Yuchen Gao,et al.  miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2 , 2021, BioMed research international.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  Lei-bo Xu,et al.  EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c , 2020, Oncogenesis.

[7]  Rui Zhang,et al.  LncRNA SNHG6 Inhibits Apoptosis by Regulating EZH2 Expression via the Sponging of MiR-101-3p in Esophageal Squamous-Cell Carcinoma , 2020, OncoTargets and therapy.

[8]  A. Yu,et al.  Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability , 2020, Drug Metabolism and Disposition.

[9]  S. Salek-Ardakani,et al.  EZH2 as a Regulator of CD8+ T Cell Fate and Function , 2020, Frontiers in Immunology.

[10]  J. Xu,et al.  Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma , 2020, Cell Death & Disease.

[11]  Yongsheng Yu,et al.  MiR-101-3p and Syn-Cal14.1a Synergy in Suppressing EZH2-Induced Progression of Breast Cancer , 2020, OncoTargets and therapy.

[12]  Weijian Guo,et al.  EZH2: a novel target for cancer treatment , 2020, Journal of Hematology & Oncology.

[13]  Li Liu,et al.  Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2 , 2020, Journal of experimental & clinical cancer research : CR.

[14]  X. Zhang,et al.  EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer , 2020, Theranostics.

[15]  Ming Yan,et al.  Long Noncoding RNA RC3H2 Facilitates Cell Proliferation and Invasion by Targeting MicroRNA-101-3p/EZH2 Axis in OSCC , 2020, Molecular therapy. Nucleic acids.

[16]  Peng-fei Zhang,et al.  Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA , 2020, Aging.

[17]  F. Fang,et al.  LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2. , 2020, Life sciences.

[18]  Qin Li,et al.  Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway , 2019, Technology in cancer research & treatment.

[19]  Zhongguo Zhou,et al.  EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma , 2019, Journal of Immunotherapy for Cancer.

[20]  D. Kuang,et al.  Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice. , 2019, Gastroenterology.

[21]  Mengjie Chen,et al.  The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection , 2019, Cellular & Molecular Immunology.

[22]  Yi Zhang,et al.  Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression , 2019, Journal of Experimental & Clinical Cancer Research.

[23]  V. Badovinac,et al.  Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf , 2018, Nature Communications.

[24]  A. Ke,et al.  LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR‐128/CD151 pathway in hepatocellular carcinoma , 2018, Journal of cellular physiology.

[25]  P. Sharma,et al.  Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy , 2018, The Journal of clinical investigation.

[26]  J. Issa,et al.  Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity , 2017, Nature Communications.

[27]  R. Xing,et al.  STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer , 2016, Molecular Cancer.

[28]  Ruilin Wang,et al.  The Functions of Histone Modification Enzymes in Cancer. , 2016, Current protein & peptide science.

[29]  D. Pasini,et al.  Emerging roles for Polycomb proteins in cancer. , 2016, Current opinion in genetics & development.

[30]  S. Orkin,et al.  Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity , 2015, Proceedings of the National Academy of Sciences.

[31]  Alessio Colantoni,et al.  Revealing protein–lncRNA interaction , 2015, Briefings Bioinform..

[32]  L. Ferrarini,et al.  Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. , 2013, The Journal of clinical investigation.

[33]  D. Nam,et al.  Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. , 2013, Cancer cell.

[34]  Yufeng Yuan,et al.  Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma. , 2017, Journal of experimental & clinical cancer research : CR.

[35]  S. Orkin,et al.  PRC2 directly methylates GATA4 and represses its transcriptional activity. , 2012, Genes & development.

[36]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..